26
Participants
Start Date
May 18, 2020
Primary Completion Date
March 15, 2023
Study Completion Date
March 15, 2023
Mirikizumab
Administered IV and SC
Seoul National University Hospital, Seoul
Icahn Sch of Med at Mt. Sinai, New York
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Pediatrics Specialists of Virginia, Fairfax
Children's Hospital of The King's Daughters Inc, Norfolk
Emory University, Atlanta
Children's Center for Digestive Health Care, LLC, Atlanta
Kyungpook National University Medical Center Chilgok Hospital, Daegu
The Abbigail Wexner Research Institute at Nationwide Children's Hospital, Columbus
Cincinnati Childrens Hospital Medical Center, Cincinnati
Riley Hospital for Children, Carmel
University of Chicago Hospital, Chicago
Washington University School of Medicine, St Louis
Cook Children's Hospital, Fort Worth
Texas Childrens Hospital, Houston
Children's Hospital of Colorado, Denver
Childrens Hospital of Orange County, Orange
UCSF Medical Center at Mission Bay, San Francisco
Seattle Children's Hospital Research Foundation, Seattle
Saiseikai Yokohamashi Tobu Hospital, Yokohama
Rambam Medical Center, Haifa
Schneider Children's Medical Center, Petah Tikva
Connecticut Children's Medical Center, Hartford
Boston Children's Hospital, Boston
MGH for Children - Waltham, Waltham
Goryeb Children's Hospital / Atlantic Health System, Morristown
University of Alberta Hospital, Edmonton
IWK Health Centre, Halifax
The Hospital for Sick Children, Toronto
The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition; Shaare Zedek Medical Center, Jerusalem
Kurume University Hospital, Kurume
Saitama Children's Medical Center, Saitama-shi
Juntendo University Hospital, Bunkyo-ku
Tokyo Medical and Dental University Hospital, Bunkyō
National Center For Child Health And Development, Setagaya-ku
Tokyo Medical University Hospital, Shinjuku-ku
Eli Lilly and Company
INDUSTRY